32 Primary Care Trusts To Spearhead Surge In Talking Therapies, UK

Health minister Ivan Lewis announced the 32 sites who will begin to roll out talking therapies around the country. Each of the 32 Primary Care Trusts (PCTs) will receive a share of the ^Alb33 million first instalment of new money announced for the purpose by Health Secretary Alan Johnson on World Mental Health Day last year (10 October).

Common Mechanisms: Inflammation, Depression And Antidepressant Response

Major depressive disorder is a common and complex condition that impacts about 15% of the population of the United States, yet very little is known about the mechanisms behind the psychiatric disorder. What is known is that there are clinical parallels between depressive symptoms and the symptoms of certain inflammatory disorders.

Medical Defence Union Advises GPs On Pitfalls Of Treating Depression, UK

The Medical Defence Union, the UK's largest medical defence organisation, has revealed it paid out nearly ^Alb3m in compensation on behalf of GP members to settle 30 claims arising from the treatment of patients with depression during a recent ten-year-period.

A Call For Standardized Measurement Of Outcomes In Depression Treatment

Rhode Island Hospital and Brown University researchers are calling on clinicians to adopt a standardized measurement of outcomes when treating depression. The commentary was published in the June edition of Primary Psychiatry.Researchers led by Mark Zimmerman, M.

Study Reveals Rural, Unmarried Women At Higher Risk For Depression

Mayo Clinic research suggests unmarried women living in rural areas have lower self-rated health status than their married counterparts. This lower health status often includes greater instances of self-assessed feelings of depression. The results of the study were recently published in the Journal of Evaluation in Clinical Practice.

Wyeth's Pristiq, A New Treatment For Major Depressive Disorder

Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced that PRISTIQTM (desvenlafaxine), a new serotonin-norepinephrine reuptake inhibitor (SNRI) approved to treat adult patients with major depressive disorder (MDD), is now available in U.

Use Of Antidepressants Reduced By Higher Co-Payments

As they struggle to contain skyrocketing medication costs, health plans across the U.S. have responded by implementing multi-tiered formularies requiring higher copayments for 'non-preferred' medications.

Suicide Prevention Group Delivers Much Needed Message To Pennsylvania's Elderly

This month, in recognition of National Mental Health Month and Older Pennsylvanians Month, Feeling Blue Suicide Prevention Council (SPC) will offer an important message to senior citizens through a public service announcement.

Potential Options For Reducing Post-Stroke Depression

An article published in the May 28 issue of JAMA reportsthat patients who took the drug escitalopram or participated in aproblem-solving therapy group during the year following a stroke werefound to have a lower risk of depression compared to patients whoreceivedplacebo.

Preventive Treatment May Ward Off Poststroke Depression

University of Iowa researchers have shown for the first time that an anti-depressant and a form of talk therapy each can prevent or delay the onset of depression in people who have had acute stroke.The findings will appear in the May 28 issue of the Journal of the American Medical Association.